BB
Bhavya Balaraj
About Bhavya Balaraj
Data last updated:
Bhavya Balaraj is a Director at Dhanvanthri Speciality Pharma Private Limited (since 2015) and Whole-Time Director at Dhanvanthri Super Speciality Private Limited (since 2023). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹299 Cr; the largest is Dhanvanthri Speciality Pharma Private Limited at ₹173 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dhanvanthri Speciality Pharma Private Limited U24100KA2015PTC079594 | Director | 31 Mar 2015 | 2015 | ₹173 Cr (FY 2024) | Active |
 Dhanvanthri Super Speciality Private Limited U46497KA2023PTC177243 | Whole-Time Director | 11 Aug 2023 | 2023 | ₹126 Cr (FY 2025) | Active |
Board colleagues of Bhavya Balaraj
| Name | DIN | Company | Designation |
|---|---|---|---|
| Guttahalli Krishnappa Shridhar | 06973473 | Dhanvanthri Speciality Pharma Private Limited , Dhanvanthri Super Speciality Private Limited | Director |
| Kushal Ashok Shah | 07743004 | Dhanvanthri Super Speciality Private Limited | Additional Director |
| Manish Kumar | 11135203 | Dhanvanthri Super Speciality Private Limited | Additional Director |
| Nikesh Kesarimal Oswal | 07895357 | Dhanvanthri Super Speciality Private Limited | Additional Director |
| Sambit Mohanty | 09302845 | Dhanvanthri Super Speciality Private Limited | Director |
| Satyendra Tiwari | 10686770 | Dhanvanthri Super Speciality Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavya Balaraj
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavya Balaraj
Bhavya Balaraj currently holds 2 directorships: Dhanvanthri Speciality Pharma Private Limited (Director, since 31 Mar 2015, revenue ₹173 Cr (FY 2024)); Dhanvanthri Super Speciality Private Limited (Whole-Time Director, since 11 Aug 2023, revenue ₹126 Cr (FY 2025)).
Bhavya Balaraj was first appointed on 31 Mar 2015 as Director at Dhanvanthri Speciality Pharma Private Limited. The most recent appointment on record is 11 Aug 2023 at Dhanvanthri Super Speciality Private Limited.
The 2 current companies of Bhavya Balaraj that report revenue have a combined latest revenue of ₹299 Cr: Dhanvanthri Speciality Pharma Private Limited ₹173 Cr (FY 2024); Dhanvanthri Super Speciality Private Limited ₹126 Cr (FY 2025).
The current boards of Bhavya Balaraj's companies include Guttahalli Krishnappa Shridhar (Dhanvanthri Speciality Pharma Private Limited), Kushal Ashok Shah (Dhanvanthri Super Speciality Private Limited), Manish Kumar (Dhanvanthri Super Speciality Private Limited), Nikesh Kesarimal Oswal (Dhanvanthri Super Speciality Private Limited), Sambit Mohanty (Dhanvanthri Super Speciality Private Limited), Satyendra Tiwari (Dhanvanthri Super Speciality Private Limited).